| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/20/2004 | US20040096861 For increase the drought tolerance of plants; gene expression inhibition |
| 05/20/2004 | US20040096857 Multiple-inspection multiplexing method and suspension for multiple-inspection multiplexing |
| 05/20/2004 | US20040096853 Isothermal amplification of nucleic acids on a solid support |
| 05/20/2004 | US20040096850 For decreasing the phosphorus waste derived from monogastric animal nutrition; feeds |
| 05/20/2004 | US20040096848 Oligomeric compounds for the modulation HIF-1alpha expression |
| 05/20/2004 | US20040096847 Regulation of human secretin receptor-like gpcr |
| 05/20/2004 | US20040096843 Methods for producing interfering RNA molecules in mammalian cells and therapeutic uses for such molecules |
| 05/20/2004 | US20040096842 Molecules involved in the regulation of insulin resistance syndrome (irs) |
| 05/20/2004 | US20040096841 Novel polypeptide-phosphatidic acid phsphatase 29.81 and the polynucleotide encoding said polypeptide |
| 05/20/2004 | US20040096839 Methods and kits for identifying and quantifying rnas and dnas associated with rna and dna binding proteins |
| 05/20/2004 | US20040096836 For diagnosis/prophylaxis/treatment of inflammation; kits |
| 05/20/2004 | US20040096832 Method for cloning of a rare, specifically mutated cell |
| 05/20/2004 | US20040096830 Modulation of protein kinase D2 expression |
| 05/20/2004 | US20040096826 Methods for creating recombination products between nucleotide sequences |
| 05/20/2004 | US20040096822 HCV antigen/antibody combination assay |
| 05/20/2004 | US20040096818 Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
| 05/20/2004 | US20040096816 Method of indentifying an eventual modification of at least one biological parameter implementing young and aged living cells |
| 05/20/2004 | US20040096466 Plasmodium falciparum antigens inducing protective antibodies |
| 05/20/2004 | US20040096462 Noval vaccine formulation consisting of dna vaccine and inactivated virus |
| 05/20/2004 | US20040096459 Polypeptides to be administered especially to humans and in particular for therapeutic use. The polypeptide to elicit an immune response upon administration to the human subject. |
| 05/20/2004 | US20040096452 Multivalent vaccines for the treatment of B-cell malignancies (e.g., lymphomas and leukemias) . The present invention also provides methods for the production of custom vaccines, including multivalent vaccines for the treatment of immune |
| 05/20/2004 | US20040096451 Preventing, treating or ameliorating symptoms associated with respiratory syncytial virus (RSV), parainfluenza virus (PIV), and/or human metapneumovirus (hMPV) infection, the methods comprising administering to a subject an effective amount of |
| 05/20/2004 | US20040096448 Nucleic acid molecules encoding a protein interacting with ser/thr kinase akt |
| 05/20/2004 | US20040096445 Method for identifying a HLA-A2 supermotif-restricted peptide, comprising: contacting a peptide consisting of 8-11 amino acids, wherein the amino acid at position two from the N-terminus of the peptide is L, I, V, M, A, T or Q and alleles |
| 05/20/2004 | US20040096442 Modified anti-egfr antibodies with reduced immunogenicity |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096432 System for the cell-specific and development-specific selection of differentiating embryonic stem cells, adult stem cells and embryonic germline cells |
| 05/20/2004 | US20040096426 Compositions and methods for identifying antigens which elicit an immune response |
| 05/20/2004 | US20040096425 Method for introducing a molecule into the cytosol of a cell in which the cell is contacted with a photosensitising agent, the cell is irradiated with light of a wavelength effective to activate the photosensitising agent and, substantially at the |
| 05/20/2004 | US20040096424 Modification of gene expression in transgenic plants |
| 05/20/2004 | US20040096397 Sulfonated diarylrhodamine dyes |
| 05/20/2004 | US20040094414 Biosensor, biosensor array, method for producing an electrode of a biosensor , method for producing a biosensor |
| 05/20/2004 | US20040093795 Floral packaging material having great masters prints thereon |
| 05/19/2004 | EP1420250A1 Gene inspection apparatus and target nucleic acid extraction method using the same |
| 05/19/2004 | EP1420070A1 Method for detecting PCR products from electrical signal generation |
| 05/19/2004 | EP1420068A1 Method of analyzing nucleic acid specifying gene showing change in expression dose in schizophrenia |
| 05/19/2004 | EP1420067A1 Chondroitin synthase |
| 05/19/2004 | EP1420066A2 Use of fullerene derivatives as DNA compaction agent |
| 05/19/2004 | EP1420065A1 Process for producing inactivated virus envelope |
| 05/19/2004 | EP1420032A1 Antibody recognizing gm1 ganglioside-bound amyloid beta-protein and dna encoding the antibody |
| 05/19/2004 | EP1420031A2 Bone morphogenetic protein (BMP)-18 compositions |
| 05/19/2004 | EP1419819A1 Method for analyzing fluid samples in substrate channels using alternating flow |
| 05/19/2004 | EP1419782A1 Use of consensus interferon for reducing the side-effects of interferon treatment in viral hepatitis |
| 05/19/2004 | EP1419392A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 05/19/2004 | EP1419275A2 Magnesium precipitate hot start method for molecular manipulation of nucleic acids |
| 05/19/2004 | EP1419274A1 Modular assembly of nucleic acid-protein fusion multimers |
| 05/19/2004 | EP1419272A1 Method and apparatus for three label microarrays |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419263A2 Yeast expression systems, methods of producing polypeptides in yeast, and compositions relating to same |
| 05/19/2004 | EP1419261A1 Permeabilisation of cells |
| 05/19/2004 | EP1419260A2 Recombinant vector derived from adeno-associated virus for gene therapy |
| 05/19/2004 | EP1419259A2 Method for repairing a mutant rna from a dna with genetic defects and for the programmed death of tumour cells by rna trans-splicing as well as a method for identifying naturally trans-spliced cellular rna |
| 05/19/2004 | EP1419258A2 Plasmids from an extremely thermophilic microorganism and derived expression vectors |
| 05/19/2004 | EP1419257A1 Methylation resistant vectors |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419255A2 A novel group of $g(a)-amylases and a method for identification and production of novel $g(a)-amylases |
| 05/19/2004 | EP1419254A2 Genetic products of ashbya gossypii, associated with transmembrane transport |
| 05/19/2004 | EP1419253A2 Isolation of proteins involved in posttranscriptional gene silencing and methods of use |
| 05/19/2004 | EP1419252A2 Genetic analysis of peyers's patches and m cells and methods and compositions targeting peyer's patches and m cell receptors |
| 05/19/2004 | EP1419251A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 05/19/2004 | EP1419250A2 Lp mammalian proteins; related reagents |
| 05/19/2004 | EP1419249A2 TIMM8b-RELATED PROTEIN |
| 05/19/2004 | EP1419248A1 Method for the selective combinatorial randomization of polynucleotides |
| 05/19/2004 | EP1419247A2 Method for the production of nucleic acids consisting of stochastically combined parts of source nucleic acids |
| 05/19/2004 | EP1419246A2 A method for identifying constitutively active mutants of mitogen activated protein kinases (mapk) and uses thereof |
| 05/19/2004 | EP1419245A2 Pseudotyped adeno-associated viruses and uses thereof |
| 05/19/2004 | EP1419244A2 Electrodes coated with treating agent and uses thereof |
| 05/19/2004 | EP1419241A2 Improved nitroreductase enzymes |
| 05/19/2004 | EP1419238A2 Novel constitutive and tissue specific plant promoters and their utilization |
| 05/19/2004 | EP1419237A2 Animal model for fatty acid amide-related neurobehaviors |
| 05/19/2004 | EP1419235A2 Knock in transgenic mammal containing a non-functional n-terminus of kv beta 1.1 subunit |
| 05/19/2004 | EP1419179A2 Antigen binding domains from fish |
| 05/19/2004 | EP1419175A2 Replikin peptides and uses thereof |
| 05/19/2004 | EP1419173A2 Peptides that bind to atherosclerotic lesions |
| 05/19/2004 | EP1419169A1 Antisense modulation of corest expression |
| 05/19/2004 | EP1419168A2 Antisense modulation of apolipoprotein b expression |
| 05/19/2004 | EP1418949A2 Inhibitor of dna methylation |
| 05/19/2004 | EP1418948A1 Replicating adenovirus vectors |
| 05/19/2004 | EP1418943A1 Methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators |
| 05/19/2004 | EP1418941A2 Vaccination against the feline immunodeficiency virus |
| 05/19/2004 | EP1418940A2 Dna expression vectors and methods of use |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418927A1 Cell compositions for use in the treatment of osteo-arthrosis, and method for producing the same |
| 05/19/2004 | EP1418814A2 Production of transduced hematopoietic progenitor cells |
| 05/19/2004 | EP1418813A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 05/19/2004 | EP1418808A1 Imaging marker transgenes |
| 05/19/2004 | EP1418806A2 Human disease modeling using somatic gene transfer |
| 05/19/2004 | EP1418805A2 Animal model with disrupted $i(fgf14) gene |
| 05/19/2004 | EP1418804A2 Reverse breeding |
| 05/19/2004 | EP1418803A1 Alteration of embryo/endosperm size during seed development |
| 05/19/2004 | EP1353943A4 NOVEL GENE ENCODING AN F-BOX PROTEIN WHICH REGULATES LEAF LONGEVITY IN i ARABIDOPSIS THALIANA /i AND MUTANT GENE THEREOF |
| 05/19/2004 | EP1294942A4 Genetic typing of the human cytochrome p450 2a6 gene and related materials and methods |
| 05/19/2004 | EP1234024B1 Artificial chromosome constructs containing nucleic acid sequences capable of directing the formation of a recombinant rna-virus |
| 05/19/2004 | EP1194541B1 Non-lactate-assimilating yeast for improving aerobic stability of silage |
| 05/19/2004 | EP1185695A4 Process for high throughput dna methylation analysis |
| 05/19/2004 | EP1151143A4 Selection of proteins using rna-protein fusions |
| 05/19/2004 | EP1141234A4 Methods and compositions for isolation of nucleic acid molecules |
| 05/19/2004 | EP1037927B1 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation |
| 05/19/2004 | EP1021553B1 Eukaryotic gene expression cassette and uses thereof |
| 05/19/2004 | EP1017810B1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |